Skip to main content

Early Detection Research Network (EDRN)

Visit the EDRN Website

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Blanke, Charles D.	Oregon Health & Science University United States	SWOG NCORP Research Base	3UG1CA189974-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Boone, Anna	University Of Missouri-Columbia United States	Pilot testing of metacognitive strategy training to address cancer-related cognitive impairment in breast cancer	1R21CA286404-01A1	Marjorie Perloff, M.D.
Boone, Anna	University Of Missouri-Columbia United States	Pilot testing of metacognitive strategy training to address cancer-related cognitive impairment in breast cancer	1R21CA286404-01A1	Marjorie Perloff, M.D.
Borges, Chad R	Arizona State University-Tempe Campus United States	Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions	5R21CA269091-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Boutros, Paul Christopher	University Of California Los Angeles United States	Germline Determinants of Prostate Cancer Evolution	5R01CA270108-03	Guillermo Marquez, Ph.D.
Bower, Julienne E	University Of California Los Angeles United States	Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings	5R01CA282416-02	Brennan Streck, Ph.D., RN, M.P.H.
Bower, Julienne E	University Of California Los Angeles United States	Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings	5R01CA282416-02	Brennan Streck, Ph.D., RN, M.P.H.
Boyer, Thomas G	University Of Texas Hlth Science Center United States	Pathological reprogramming of the m6A epitranscriptome in uterine fibroids	5R01HD106285-05	Goli Samimi, Ph.D., M.P.H.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08	Matthew Young, Ph.D.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08	Matthew Young, Ph.D.
Brinkman, Tara M	St. Jude Children'S Research Hospital United States	Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma	4R33CA280978-02	Rachel Altshuler, Ph.D.
Brinkman, Tara M	St. Jude Children'S Research Hospital United States	Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma	4R33CA280978-02	Rachel Altshuler, Ph.D.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-03	Rachel Altshuler, Ph.D.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-03	Rachel Altshuler, Ph.D.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-03	Rachel Altshuler, Ph.D.

News and Events